ADVERTISEMENT
AstraZeneca – BRIEF-AstraZeneca Says Forxiga Authorised In Japan For Coronary heart Failure
Nov 30 (Reuters) – AstraZeneca PLC:
* ASTRAZENECA PLC – FORXIGA APPROVED IN JAPAN FOR HEART FAILURE
* ASTRAZENECA- FORXIGA (DAPAGLIFLOZIN) APPROVED IN JAPAN FOR TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE (HF) WHO ARE RECEIVING STANDARD OF CARE
* ASTRAZENECA- APPROVAL WAS (BA)SED ON POSITIVE RESULTS FROM LANDMARK DAPA-HF PHASE III TRIAL Supply textual content for Eikon: Additional firm protection:
